Vial label design and print may vary between batches. Product specifications remain unchanged.
At a glance
Strength
10mg per vial
Form
Lyophilised powder
Purity
≥ 99% (HPLC)
CAS number
129954-34-3
Molecular weight
751.9 g/mol
Certificate of Analysis
Batch SK-10-25 · Prime Peptides UK
Neuroactive & cognitive
Selank
Synthetic research peptide · 10mg · CAS 129954-34-3
£29.95 In stock · ready to shipper vial · £3.00 per mg
Selank 10mg is coming soon. It goes on sale as soon as its batch certificate is published - every vial we sell has a matching CoA.
Bank transferBitcoin Encrypted checkout · card details are never taken on this site
Multi-item discount. Add any 2 items for 4% off the whole order, 7% at 3, 10% at 4. Applied automatically at checkout.
Free
Free lab add-on. Bacteriostatic water is included with every peptide order at no extra cost.
Lab essentials tap to add to this order
RUOResearch Use Only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and accept responsibility for safe, lawful handling.
Same-day dispatch
Orders before 3:00 PM leave the same working day, tracked, in plain packaging. Free UK delivery over £200.
Secure payment
Bank transfer or Bitcoin over an encrypted checkout. No card details are stored or handled on this site.
Batch tested
Every batch is HPLC and mass spectrometry tested, and its certificate is published before it ships.
Selank 10mg≥99% HPLC · In stock
£29.95
Compound Overview
What Is Selank 10mg?
Selank 10mg is a laboratory research version of synthetic heptapeptide (Selank), which is extracted from studies of the naturally occurring tetrapeptide tuftsin. It has been studied for its role in neurotransmission, stress-related behaviour and neurobiological signalling due to its seven-amino-acid sequence. The chosen dosage of 10mg allows for precise analysis and research in a laboratory setting. Prime Peptides UK sells Selank for use in scientific and laboratory research solely.
Selank is a synthetic peptide, which has a structure of seven amino acids: Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). According to the scientific literature, it is a synthetic analogue of tuftsin, a naturally occurring tetrapeptide that plays a role in biological signalling. It has been experimentally explored as it relates to interactions with a range of neurochemical and molecular processes with respect to its extended sequence.
Selank is chemically C33H57N11O9 with a molecular weight of ~751.9 g/mol. These properties, along with its well-defined sequence, help define it as a research material and for analytical documentation.
The 10mg dosage is only for the form of the product (Selank). It is not a dose recommendation. The format allows researchers to source Selank 10mg UK and easily add it to their own research protocols as dictated by their own experiments.
Technical Data
Selank Product Specifications
Technical Specification Sheet
SELANK · 10MG · RUO
Product Name
Selank 10mg
Compound
Selank
Peptide Type
Synthetic heptapeptide
Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Sequence Code
TKPRPGP
Molecular Formula
C33H57N11O9
Molecular Weight
751.9 g/mol
Research Quantity
10mg
Format
Laboratory research material
Documentation
Batch-specific Certificate of Analysis with every batch
Intended Use
Scientific and laboratory research only
CAS Number
129954-34-3
Purity
≥99% by HPLC
The sequence, formula and molecular weight above refer to Selank itself; researchers should consult the documentation accompanying a particular batch for the exact supplied material and analytical results.
The Science
Scientific Background of Selank
Selank was developed through peptide research involving tuftsin and its derivatives. Rather than functioning as a simple copy of tuftsin, Selank incorporates an extended amino-acid sequence that has become the subject of experimental work examining neurochemical signalling and behavioural responses.
One area receiving particular attention is GABAergic neurotransmission. Experimental research has investigated whether Selank influences GABA-related receptor activity and gene expression associated with neurotransmission. A published molecular review reported findings consistent with concentration-dependent modulation of GABA receptor binding, while separate animal research identified changes in the expression of genes associated with GABAergic signalling.
Other laboratory investigations have considered neurotrophic factors, enkephalin metabolism and responses in experimental stress models. For example, a rat study examined Selank in relation to brain-derived neurotrophic factor (BDNF) in the hippocampus and prefrontal cortex.
Research Context
These findings provide research hypotheses rather than established therapeutic conclusions. Much of the mechanistic literature is preclinical, and results from experimental models should not be interpreted as evidence of a clinical benefit.
Laboratory Focus
Why Is Selank Studied in Laboratory Research?
Selank is of interest, as its biological activity has been investigated in a number of interrelated fields, and not along a known molecular pathway. This makes the peptide interesting to those studying the effect of peptide signaling on other neurochemical systems.
Laboratory Research
Experimental studies related to GABA pathways have been published. It has also been investigated if Selank affects enkephalin degradation, and previous work has shown that it inhibits enzymes that are responsible for the hydrolysis of enkephalin.
Neurological Pathways
Responses to experimentally induced stress and other controlled conditions have been studied using behavioural measures in animal models. Diazepam has also been studied with Selank in rat models, indicating interest in the comparison of peptide related signalling to established neuropharmacological pathways.
Receptor Signalling
Several experimental studies have investigated the memory-related endpoints and BDNF levels of specific brain regions. Such studies enable the scientists to ask questions about peptide signalling, neurotransmission and molecular responses.
Interpreting Results
These are still under investigation. Experimental studies, especially those performed in laboratory animals or isolated biological systems, do not necessarily extrapolate to humans.
Product Format
Understanding the Selank 10mg Research Format
10mg
Nominal Research Quantity
A 10mg Selank product contains a defined 10 milligrams of research material according to its labelled quantity. This distinction matters because the strength displayed on a research product describes the amount supplied rather than an instruction for administration.
Different quantities of laboratory peptides may exist because research programmes vary considerably in scale. A laboratory conducting several analytical procedures, comparative assays or repeat experiments may have different material requirements from a small preliminary investigation. Selection therefore depends on the research protocol, number of planned analyses, analytical methodology and institutional procedures.
The Selank 10mg format can consequently be evaluated as a material quantity within a laboratory procurement process. Researchers should calculate their own requirements based on approved experimental protocols and relevant standard operating procedures.
No human or animal dosage should be inferred from the vial quantity. The presence of 10mg on the label does not establish an appropriate concentration, experimental dose or method of administration.
Verification
Identity Testing, Purity and Certificate of Analysis
The knowledge of the material under study is crucial for peptide research. Therefore, when sourcing Selank peptides for research, it is essential that analytical documentation is taken into account.
Batch-Specific CoA
A Certificate of Analysis may contain batch related information and the analysis results as reported. Researchers should look for clear identification of the compound, batch/lot information, relevant test method details, and test results that correlate with the supplied material.
HPLC Analysis
Peptide analysis is frequently performed by high-performance liquid chromatography (HPLC) to determine the purity of HPLC runs and the relative amount of components in a sample. An HPLC result cannot, however, be used to answer all questions regarding peptide identity or quality.
Identity vs Purity
When further analytical methods have been carried out, they should consider the contribution of each method, rather than just using the headline purity number.
Batch traceability is particularly useful when using Selank 10mg as it can link the research material to the documentation. Researchers should always consult the COA provided for the specific batch and never assume results from another batch are valid.
Handling
Storage and Laboratory Handling
Documentation First
Selank research material should be managed using appropriate laboratory procedures designed to protect sample integrity. Storage circumstances can have an impact on peptide stability, thus researchers should follow the directions provided with the product as well as any requirements indicated in its batch documentation.
Environmental Conditions
Keep the substance safely in its original labeled packing, protected from undue environmental exposure until you need it for laboratory work. The documented storage requirements of the supplier should be considered in terms of temperature, moisture and light.
Contamination Control
Appropriate laboratory practice also involves reducing contamination risk, maintaining accurate sample identification and recording relevant storage conditions. Laboratories should incorporate Selank into their own established SOPs for peptide materials.
Note
These principles concern laboratory material management only and are not instructions for preparing Selank for human administration.
The researchers, who are comparing the Selank 10mg in the UK suppliers, need to focus on more than the name of the product and the label's quantity. Purchasing criteria that are useful are those where the compound can be identified, batch traceability is available, analytical documents are available to view, and there is clear information about the intended usage of the material for research purposes.
A batch specific COA is especially valuable as it enables the researchers to be able to check reported analytical data on the product received. The packaging and labelling should also allow easy identification of the compound and amount in a laboratory inventory.
Having the dispatch office based in the UK does not guarantee quality of the analysis, but it can make domestic research procurement easier. Documentation, testing details and transparency on the part of the supplier should be taken into account not just the promotional claims, by all scientists looking at where to purchase Selank 10mg UK for legitimate laboratory use.
Analytical Records
Batch certificates for Selank
Every order ships with the CoA matched to its batch number, and the analytical records
are published here - open the certificate before you order, or cross-check the one in
your parcel.
The 10mg figure describes the labelled quantity of Selank research material supplied. It should not be interpreted as a recommended dose, concentration or amount for administration. Laboratories should determine material requirements from their experimental design, analytical methods and approved research protocols.
What is the amino-acid sequence of Selank ?
Selank is a seven-amino-acid peptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, abbreviated TKPRPGP. PubChem records the molecular formula as C33H57N11O9 and molecular weight as approximately 751.9 g/mol.
What makes Selank different from tuftsin ?
Selank is related structurally to tuftsin but contains an extended seven-amino-acid sequence. Scientific literature commonly describes it as a tuftsin-derived or tuftsin-related synthetic heptapeptide. Researchers have studied the resulting molecule in experimental work involving neurotransmission, behavioural responses and other biological pathways.
What areas of Selank research have been investigated?
Published work has examined areas including GABA-associated signalling, gene expression related to neurotransmission, enkephalin metabolism, BDNF and behavioural responses in animal models. These findings should be interpreted according to the individual study design; preclinical results do not establish therapeutic effects in humans.
Why is a batch-specific COA important for Selank 10mg?
A Certificate of Analysis is distinctive to a batch and associates analytical information with the individual research material given. Depending on the tests performed it may offer compound identification, batch information, test technique and analytical results presented. Researchers should evaluate the actual document rather than assuming that all Selank batches have identical analytical characteristics.
Is Selank 10mg intended for human use in the UK?
No. This Selank 10mg product is intended solely for laboratory research use and is not sold as a medicine, supplement or as a product for self-administration. The information found here relates to scientific research and product identification only and is not a diagnosis, treatment, prevention or management of any medical condition.
PG
Medically & Scientifically Reviewed By
Dr. Priyanka Goel
Scientific & Medical Content Reviewer
Reviews research content against current published literature and UK regulatory guidance, ensuring compound information is accurate, referenced and presented for research use only.
Selank 10mg is made available for proper research, analysis and scientific studies in the laboratory. It is not for human consumption, self-medication, diagnosis or treatment. The information contained on this page is not meant to be medical advice or a recommendation for the clinical use of any product. The above experimental and preclinical results do not necessarily imply proven human health benefits.
